March 30, 2022 – A new study found that psychedelic drugs such as lysergic acid diethylamide (LSD) may be effective at reducing symptoms of stress-related anxiety and in mental health treatment.
The study’s research team was led by Dr. Gabriella Gobbi, a professor in the Department of Psychiatry at the Research Institute of the McGill University Health Center (RI-MUHC) in Montreal, Canada.
The study, published in the journal NeuropsychopharmacologyTrusted Source, also involved eight other neuroscientists and involved a collaboration between RI-MUHC, Vita-Salute San Raffaele University, Italy, and the Pharmaceutical and Pharmacological Sciences center at the University of Padua, Italy.
Dr. Danilo De Gregorio, an assistant professor of pharmacology at San Raffaele University, was the lead author of this research paper. Previous studies by Dr. De Gregorio and Dr. Gobbi to pinpoint the neurobiological mechanisms by which LSD relieves anxiety had been elusive and unclear.
EMR MATTERS – October 2024 - The challenge is that many in the behavioral health…
TOO LITTLE, TOO LATE? – Dec. 19, 2024 - Assembly Bill 56 (AB 56) proposes…
AND STOPPED DIGGING – Dec. 4, 2024 - In a new interview with The Times,…
NOT JUST IN PENCILS – Dec. 8, 2024 - Americans born before 1966 experienced “significantly…
AS SUCCESSFUL AS EVER – Dec. 3, 2024 - Family Affair actor Johnny Whitaker looked…
ALANON Plus – Dec. 7, 2024 - A high percentage of treatment failures occur due…